| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/24/1998 | CA2285701A1 .beta.-catenin, tcf-4, and apc interact to prevent cancer |
| 09/24/1998 | CA2284581A1 Radiolabelled somatostatin receptor ligands for diagnosis and therapy |
| 09/24/1998 | CA2284039A1 Methods and kits for treating and diagnosing leiomyomas |
| 09/24/1998 | CA2283961A1 Pyrrolo[2,3d]pyrimidines and their use as tyrosine kinase inhibitors |
| 09/24/1998 | CA2283737A1 Human tumorigenesis associated protein, htap |
| 09/24/1998 | CA2283732A1 Novel carboxylic acid derivatives, their preparation and use in treating cancer |
| 09/24/1998 | CA2283690A1 Human tumor suppressor |
| 09/24/1998 | CA2283297A1 New formulation |
| 09/24/1998 | CA2281738A1 Modulators of the function of receptors of the tnf/ngf receptor family |
| 09/24/1998 | CA2277179A1 Hydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same |
| 09/23/1998 | EP0866128A2 Recombinant ricin toxin |
| 09/23/1998 | EP0866126A1 CDNA clone HNFDY20 that encodes a novel human 7-transmembrane receptor |
| 09/23/1998 | EP0866063A1 10, 11-Methanodibenzosuberane derivatives used as chemosensitizing agents |
| 09/23/1998 | EP0865609A1 Method of diagnosing and treating epithelioma |
| 09/23/1998 | EP0865492A1 Specific binding members for human carcinoembryonic antigen, materials and methods |
| 09/23/1998 | EP0865491A1 Compounds having lectin properties and biological uses thereof |
| 09/23/1998 | EP0865489A1 Modified vegf antisense oligonucleotides |
| 09/23/1998 | EP0865448A1 Apoptosis induced by monoclonal antibody anti-her2 |
| 09/23/1998 | EP0865445A1 3-aminoethyl-n-amidino-2,5-dihydropyrrole derivatives having arginine mimetic properties |
| 09/23/1998 | EP0865440A1 Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives |
| 09/23/1998 | EP0865428A1 Vitamin d analogues |
| 09/23/1998 | EP0865426A1 Amino acid derivatives, medicaments containing said compounds and methods of producing said compounds |
| 09/23/1998 | EP0865339A1 Metalloproteinase inhibitors |
| 09/23/1998 | EP0865298A1 Drug therapy |
| 09/23/1998 | EP0865295A1 Use of human chorionic gonadotropin in the treatment of kaposi's sarcoma |
| 09/23/1998 | EP0865293A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 09/23/1998 | EP0749481B1 Humanized monoclonal antibodies against human interleukin-4 |
| 09/23/1998 | CN1194009A 结肠特异性基因及蛋白质 Colon-specific genes and proteins |
| 09/23/1998 | CN1194000A Methods for enhancement of protective immune responses |
| 09/23/1998 | CN1193978A Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases |
| 09/23/1998 | CN1193910A Use of alicyclic diamines as immunomodulators |
| 09/23/1998 | CN1193623A Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them |
| 09/23/1998 | CN1193530A Medicine for curing and preventing malignant tumors and preparation thereof |
| 09/23/1998 | CN1193513A Use of pyrimidine derivatives for prevention of cancer, on their own or in combination with other therapeutic measures |
| 09/23/1998 | CN1193512A Application of tea component in preparation of pharmaceutics for leukemia |
| 09/22/1998 | US5811562 Pharmceutical compositions for the treatment of osteoporosis, wound healing, transplant rejection, rheumatoid arthritis |
| 09/22/1998 | US5811535 Human cartilege gp39-like gene |
| 09/22/1998 | US5811518 Polypeptide having specified amino acid sequence, capable of being specifically bound by antibody |
| 09/22/1998 | US5811454 3-fluorobenzamides with nitrogen mustard groups; anticarcinogenic agents |
| 09/22/1998 | US5811452 Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof |
| 09/22/1998 | US5811449 Administering a suppressor pyrrolidine dithiocarbamate to prevent the oxidation of a polyunsaturated fatty acid |
| 09/22/1998 | US5811421 Naphthyl and dihydronaphthyl intermediates, compounds, compositions, and methods |
| 09/22/1998 | US5811420 Fungarrestins |
| 09/22/1998 | US5811410 Nonsteroidal antiinflammatory drugs |
| 09/22/1998 | US5811392 Conformationally constrained backbone cyclized peptide analogs |
| 09/22/1998 | US5811304 Nucleic acid molecules encoding retinoblastoma protein-interacting zinc finger proteins |
| 09/22/1998 | US5811288 Isoform gene for focal adhesion protein paxillin |
| 09/22/1998 | US5811267 For drug or toxin targeting, imaging, therapy |
| 09/22/1998 | US5811097 Decreasing growth of tumor cells by administering blocking agent which binds to extracellular domain of cytotoxic t-lymphocyte-associated molecule and inhibits signaling |
| 09/19/1998 | CA2224128A1 Cdna clone hnfdy20 that encodes a novel human 7-transmembrane receptor |
| 09/17/1998 | WO1998040738A1 Prostate specific antigen substrates |
| 09/17/1998 | WO1998040508A1 Adenoviral vectors with modified tropism |
| 09/17/1998 | WO1998040492A1 Compositions and methods for elimination of unwanted cells |
| 09/17/1998 | WO1998040488A1 Anti-alphabeta3 humanized monoclonal antibodies |
| 09/17/1998 | WO1998040483A2 28 human secreted proteins |
| 09/17/1998 | WO1998040482A1 Growth factor receptor binding protein |
| 09/17/1998 | WO1998040479A1 Modified protein kinase a-specific oligonucleotides and methods of their use |
| 09/17/1998 | WO1998040404A2 Secreted proteins and polynucleotides encoding them |
| 09/17/1998 | WO1998040403A1 Psca: prostate stem cell antigen |
| 09/17/1998 | WO1998040400A1 Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the c-terminus |
| 09/17/1998 | WO1998040383A1 Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with n- or c-linked imidazoles |
| 09/17/1998 | WO1998040381A1 Inhibitors of impdh enzyme |
| 09/17/1998 | WO1998040380A1 Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation |
| 09/17/1998 | WO1998040092A1 Dolastatin-15 derivatives in combination with taxanes |
| 09/17/1998 | WO1998040080A1 Oxyalkylene phosphate compounds and uses thereof |
| 09/17/1998 | WO1998040068A1 Heterocyclic agents |
| 09/17/1998 | WO1998040065A1 Hydroxy and ether-containing oxyalkylene esters and uses thereof |
| 09/17/1998 | WO1998040064A1 Butyrate prodrugs derived from lactic acid |
| 09/17/1998 | WO1998040061A1 Use of r-nsaid's for the prevention of alzheimer's disease |
| 09/17/1998 | WO1998040058A2 Down-regulation of gene expression by colorectal administration of synthetic oligonucleotides |
| 09/17/1998 | WO1998040052A1 Cationic lipid compositions targeting angiogenic endothelial cells |
| 09/17/1998 | WO1998040049A2 Specific magnetosome, method for the production and use thereof |
| 09/17/1998 | WO1998031394A3 Tissue factor methods and compositions for coagulation and tumor treatment |
| 09/17/1998 | WO1998030683A3 Nuclear transfer with differentiated fetal and adult donor cells |
| 09/17/1998 | WO1998030242A3 Photochemotherapeutic compositions |
| 09/17/1998 | WO1998024905A3 Secreted proteins and polynucleotides encoding them |
| 09/17/1998 | DE19706490C1 Verfahren zur Herstellung von Säureamiden und zur Metallierung von Verbindungen und Verwendung der nach den Verfahren hergestellten Verbindungen Process for the preparation of acid amides and the metalation of compounds and use of the compounds prepared by the processes |
| 09/17/1998 | CA2297164A1 Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the c-terminus |
| 09/17/1998 | CA2284518A1 Anti-alphabeta3 humanized monoclonal antibodies |
| 09/17/1998 | CA2284137A1 Prostate specific antigen substrates |
| 09/17/1998 | CA2283678A1 28 human secreted proteins |
| 09/17/1998 | CA2283626A1 Modified protein kinase a-specific oligonucleotides and methods of their use |
| 09/17/1998 | CA2283461A1 Adenoviral vectors with modified tropism |
| 09/17/1998 | CA2283296A1 Growth factor receptor binding protein |
| 09/17/1998 | CA2283193A1 Secreted proteins and polynucleotides encoding them |
| 09/17/1998 | CA2283173A1 Hydroxy and ether-containing oxyalkylene esters and uses thereof |
| 09/17/1998 | CA2283162A1 Oxyalkylene phosphate compounds and uses thereof |
| 09/17/1998 | CA2283127A1 Heterocyclic agents |
| 09/17/1998 | CA2282398A1 Inhibitors of impdh enzyme |
| 09/17/1998 | CA2253588A1 Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation |
| 09/16/1998 | EP0864651A2 Promoter of the cdc25B gene, its preparation and use |
| 09/16/1998 | EP0864327A1 Use of pyrimidin derivatives to prevent cancer |
| 09/16/1998 | EP0863992A1 Product and process to regulate actin polymerization |
| 09/16/1998 | EP0863984A1 Methods and compositions for the diagnosis and treatment of cancer |
| 09/16/1998 | EP0863917A1 Targeted cytotoxic anthracycline analogs |
| 09/16/1998 | EP0863911A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION |
| 09/16/1998 | EP0863903A1 Synthetic metal-substituted bacteriochlorophyll derivatives and use thereof |
| 09/16/1998 | EP0863899A1 Pyridopyrimidines |
| 09/16/1998 | EP0863883A1 Alpha-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors |
| 09/16/1998 | EP0863881A1 Benzimidazole derivatives and their use in the prevention and/or the treatment of bone diseases |